MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1353.04%
Quick Ratio
1353.04%
Cash Ratio
1322.11%
Debt to Asset Ratio
7.39%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2026-06-30
2026-03-31
2025-12-31
Cash and cash equivalents
11,542 3,080 5,143
Prepaid expenses
270 389 -
Other current assets
-33 27
Total current assets
11,812 3,502 5,170
Total assets
11,812 3,502 5,170
Accounts payable
683 850 470
Due to related party
96 98 91
Accrued expenses related party
73 45 23
Accrued expenses and other current liabilities
21 21 21
Total current liabilities
873 1,014 605
Total liabilities
873 1,014 605
Common stock 0.0001 par value 560,000,000 shares authorized 49,845,993 and 47,343,297 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
5 5 5
Additional paid-in capital
114,493 104,662 104,195
Accumulated deficit
-103,559 -102,179 -99,635
Total stockholders equity
10,939 2,488 4,565
Total liabilities and stockholders equity
11,812 3,502 5,170
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$11,542K Prepaid expenses$270K Total current assets$11,812K Total assets$11,812K Total liabilities andstockholders equity$11,812K Total stockholdersequity$10,939K Total liabilities$873K Accumulated deficit-$103,559K Additional paid-in capital$114,493K Total currentliabilities$873K Common stock 0.0001 parvalue 560,000,000...$5K Accounts payable$683K Due to related party$96K Accrued expenses related party$73K Accrued expenses andother current...$21K

Polaryx Therapeutics, Inc. (PLYX)

Polaryx Therapeutics, Inc. (PLYX)